Perri Patrizia, Bachetti Tiziana, Longo Luca, Matera Ivana, Seri Marco, Tonini Gian Paolo, Ceccherini Isabella
Laboratory of Neuroblastoma Research, Fondazione Italiana per la Lotta al Neuroblastoma, c/o Advanced Biotechnology Centre, L.go R. Benzi 10, 16132 Genoa, Italy.
Oncogene. 2005 Apr 21;24(18):3050-3. doi: 10.1038/sj.onc.1208532.
Neuroblastoma (NB) is a childhood malignancy originating from neural crest cells, which seldom occurs in association with other neurocristopathies. Owing to the rarity of familial NB cases, only a few linkage data are available and no mutations in candidate genes have been demonstrated up till now. Germline mutations in a small proportion of NB patients have been recently reported in the paired-like homeobox 2B (PHOX2B) gene, suggesting its role in NB predisposition. On the basis of this indication, we screened three Italian families with recurrence of NB and one family with occurrence of ganglioneuroblastoma and isolated Hirschsprung disease for PHOX2B defects. Our analysis did not show any mutation, excluding PHOX2B as the NB susceptibility gene in the families we analysed. Our findings combined with those derived from other PHOX2B mutation screenings and from genome-wide linkage analysis support a remarkable genetic heterogeneity of NB and suggest an oligogenic model of disease transmission. Furthermore, as PHOX2B mutations were mainly observed in some NB families with multifocal and syndromic NB, features that are missing in the families we have studied, we suggest they represent second-site modifications responsible for a specific phenotype rather than causal mutations of a major locus.
神经母细胞瘤(NB)是一种起源于神经嵴细胞的儿童恶性肿瘤,很少与其他神经嵴病变同时发生。由于家族性NB病例罕见,目前仅有少量连锁数据,且尚未证实候选基因存在突变。最近有报道称,一小部分NB患者存在成对样同源盒2B(PHOX2B)基因的种系突变,提示该基因在NB易感性中发挥作用。基于这一迹象,我们对三个有NB复发的意大利家庭以及一个患有神经节神经母细胞瘤并伴有孤立性先天性巨结肠病的家庭进行了PHOX2B缺陷筛查。我们的分析未发现任何突变,排除了PHOX2B作为我们所分析家庭中NB易感基因的可能性。我们的研究结果与其他PHOX2B突变筛查以及全基因组连锁分析的结果相结合,支持了NB显著的遗传异质性,并提示了一种寡基因疾病传播模型。此外,由于PHOX2B突变主要在一些具有多灶性和综合征性NB的家庭中观察到,而这些特征在我们研究的家庭中并不存在,我们认为它们代表了导致特定表型的第二位点修饰,而非主要位点的致病突变。